Andrew Kochan presented the PARADISE-MI Trial. The trial's goal was to assess the efficacy and safety of sacubitril/valsartan compared with ramipril in the acute myocardial infarction (AMI) population. This trial enrolled 5661 patients with a duration…
Read More
Jason Gencher presented the APAF-CRT Mortality Trial which was an international, open-label, blinded outcome trial of patients with severely symptomatic permanent atrial fibrillation for greater than 6 months, a narrow QRS (≤110 ms) and at least one HF…
Read More
Cathevine Yang presented the LAAOS-III Trial which was a multicenter, randomized trial of patients with atrial fibrillation, a CHA2DS2-VASc score of at least 2 and who were scheduled to undergo cardiac surgery for another…
Read More
The 4th VanSCAD conference will be held virtually on February 19, 2022. An international team of SCAD experts will be on faculty to provide a contemporary update on SCAD during…
Read More
Madeleine Barker presented the DEFINE PCI Trial 1 Year Outcomes. The DEFINE PCI trial (Physiologic Assessment of Coronary Stenosis Following PCI) was a multicenter, prospective, observational study in which a blinded iFR pull back…
Read More
Isabel Kim presented the AVATAR Trial, which is an investigator-initiated international prospective randomized controlled trial that evaluated the safety and efficacy of early SAVR compared to conservative treatment in the treatment of asymptomatic patients with…
Read More
Dr. Nav Malhi presented the CTCR-MVS Trial, which is a randomized, surgical trial comparing mitral valve surgery with or without tricuspid annuloplasty (TA) among patients who were undergoing mitral-valve surgery for degenerative mitral regurgitation with either moderate…
Read More